On the one hand, segregation analyses of EOAD cases have been linked to mutations in the genes encoding APP, presenilin 1 (PSEN1), and PSEN2 [158], which are involved in the main molecular mechanism of AD pathogenesis, triggering the cascade of amyloid-β deposition, resulting in cognitive impairments. This evidence concerns the gene PSEN1 and Cognitive impairment.